Interesting. And confusing .. like CYDY results. It appears they had to exclude critical patients (reported for only those on HFNC; overall study criteria excluded if on mechanical ventilation >7 days or on ECMO, so analysis excluded any mech. Vent.) and also they had to excluded entire sites (10 total, but excluded from analysis regional centers) without much justification.

Maybe I misunderstood their presentation, and will hear more in a few hours.

Will see if they are as transparent as CYDY with presentation of full results. It certainly appears their subgroup analysis was significant, but need more information. Will see if FDA goes for EUA, and how quickly it responds to theirs and CYDYs based on subgroup analysis. I don't remember the 28 day endpoint being significant before but now it is?